Abstracts FAQ
No, all presentations will take place at the Ernest N. Morial Convention Center in New Orleans, Louisiana. There will not be an option to present virtually. In the event that none of the authors can attend to present, the abstract will need to be withdrawn from the meeting.
Regular Abstract submission will be open from September 29, 2025 until January 5, 2026 at 5:00 p.m. ET. Late Breaking Abstract submission will be open from January 26, 2026 until March 9, 2026 at 5:00 p.m. ET.
Abstracts submitted during regular submission will be considered for a 15-minute oral presentation, poster presentation or published only. There is a non-refundable processing fee of $90.00 (USD) charged per submission.
Abstracts submitted during late breaking submission are only considered for poster presentations. There is a non-refundable processing fee of $135.00 (USD) charged per submission.
Yes, a non-refundable $90.00 (USD) processing fee is charged per regular abstract submission. A non-refundable $135.00 (USD) processing fee is charged per late breaking abstract submission.
No, you are not required to be an ADA member to submit an abstract.
ADA typically does not accept the following submission types:
- Case Studies/Case Reports
- Literature Reviews – An abstract fully based on a review article is not eligible. The submission may cite an article to provide background for unpublished research.
- Study Designs
- Trial-In-Progress – An abstract must contain preliminary data/findings.
There is no limit to the number of abstracts an author may submit; however, an author may only serve as the Presenting Author on two regular submission abstracts and one late breaking abstract submission. It is the author’s responsibility to designate a new presenter for presentation conflicts that arise due to multiple submissions.
The author listed first in the author block is referred to as the first author. The first author does not have to serve as the presenting author. The presenting author can be any author listed in the author block.
The recommended structure for abstracts can be found in the abstract submission guidelines.
No, abstracts must not have been published as a manuscript or an abstract prior to the 2026 Scientific Sessions (June 5–8, 2026).
No, abstracts must not have been presented at another national or international meeting held prior to the 2026 Scientific Sessions (June 5–8, 2026).
Regular Abstract Submission: In early-March 2026, a letter will be emailed to the abstract's presenting author, notifying him/her of the abstract's acceptance status.
Late Breaking Abstract Submission: In early-April 2026, a letter will be emailed to the abstract's presenting author, notifying him/her of the abstract's acceptance status.
To ensure receipt of your notification, it is important that you provide a correct email address for the presenting author.
All abstract titles, authors, and presentation details will be released by mid-April in the Online Planner.
The presenter must be a co-author listed on the abstract at the time of submission. If the original designated presenting author is unable to attend the Scientific Sessions, it is their responsibility to assign a co-author and inform the ADA. To make a presenting author change, please email abstracts@diabetes.org with the name and email address of the new presenting author. Please include the abstract title, control number, and/or presentation number.
Young Investigator awards will be given to a limited number of authors of abstracts that have been accepted for oral or poster presentation at the 2026 Scientific Sessions. Applications will be sent to presenting authors at the time of abstract acceptance notification in early-March. We do not offer travel grants for abstracts accepted during late breaking submission.
Those who have received a travel grant from the ADA within the past two years (2024 or 2025) are not eligible.
No changes of any kind may be made after the deadline.
No. All author information should be carefully reviewed for accuracy prior to completing the abstract submission. Additions or deletions of author names are not permitted after the submission deadline.
All abstracts are published online in the journal Diabetes®.
For permission to resubmit or use an abstract published by ADA, please contact our Publications Department at permissions@diabetes.org. Please include the publication year, publication number, abstract title, and author name(s) with your request.
Visit our abstract citation page for instructions and citation examples.